We have previously reported that LPA induces the fibrosis of renal mesangial cells, and that treatment with ki16425, an LPAR1/3 antagonist, inhibits renal fibrosis and improves DN in db/db type 2 diabetic mice [10]. Here, LPAR1 is linked to liver dysplastic nodule.